← Back to Clinical Trials
Recruiting NCT04988009

NCT04988009 Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04988009
Status Recruiting
Phase
Sponsor M.D. Anderson Cancer Center
Condition Central Nervous System Neoplasm
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2020-08-20
Primary Completion 2026-12-31

Trial Parameters

Condition Central Nervous System Neoplasm
Sponsor M.D. Anderson Cancer Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-08-20
Completion 2026-12-31
Interventions
Electronic Health Record ReviewSurvey Administration

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Eligibility Criteria

Inclusion Criteria: * Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease * Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be * An in-person visit * A telemedicine appointment Exclusion Criteria: * Encounter occurred with the assistance of official language translation support * Patients with telephone encounters (without interactive video) * New patient or consult visits * Neither patient nor caregiver present during the visit are available or able to answer survey questions

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology